Skip to main content
OpenTrials

Clinical trial condition

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

Explore clinical trials studying Precursor B-Cell Lymphoblastic Leukemia-Lymphoma. Study availability and eligibility vary by location and protocol.

30 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma trial results

Recruiting

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

NCT03959085

Conditions
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, Burkitt Lymphoma, +25 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • USA Health Strada Patient Care Center Mobile, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
View all 231 locations
View Trial Details
Recruiting

HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies

NCT05745714

Conditions
Acute Lymphoblastic Leukemia, in Relapse, Disease Attributes, Hematologic Diseases, +19 more
Locations
  • St. Anna Kinderspital Vienna, Austria
  • Universitair Ziekenhuis Gent Ghent, Belgium
  • Rigshospitalet Copenhagen Copenhagen, Denmark
  • Helsinki University Hospital, New Children's Hospital Helsinki, Finland
View all 33 locations
View Trial Details
Recruiting

HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies

NCT05658640

Conditions
Acute Lymphoblastic Leukemia, in Relapse, Disease Attributes, Hematologic Diseases, +19 more
Locations
  • St. Anna Kinderspital Vienna, Austria
  • Universitair Ziekenhuis Gent Ghent, Belgium
  • Rigshospitalet Copenhagen Copenhagen, Denmark
  • Helsinki University Hospital, New Children's Hospital Helsinki, Finland
View all 36 locations
View Trial Details
Recruiting

HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies

NCT05751044

Conditions
Acute Lymphoblastic Leukemia, Disease Attributes, Hematologic Diseases, +19 more
Locations
  • St. Anna Kinderspital Vienna, Austria
  • Universitair Ziekenhuis Gent Ghent, Belgium
  • Rigshospitalet Copenhagen Copenhagen, Denmark
  • Helsinki University Hospital, New Children's Hospital Helsinki, Finland
View all 33 locations
View Trial Details

Related conditions